Cargando…

784: THE IMPACT OF THE CORONAVIRUS PANDEMIC AND GOVERNMENT LOCKDOWNS ON LIVER DISEASE HOSPITALIZATIONS, INPATIENT MORTALITY, AND LIVER TRANSPLANT SURGERY IN CALIFORNIA: A POPULATION-LEVEL ANALYSIS

Detalles Bibliográficos
Autores principales:	Adekunle, Ayooluwatomiwa D., Rubens, Muni, Tariq, Tahniyat, Sedarous, Mary, Okafor, Philip N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AASLD Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212402/ http://dx.doi.org/10.1016/S0016-5085(22)63415-2

Ejemplares similares

877: THE IMPACT OF THE CORONAVIRUS PANDEMIC AND GOVERNMENT LOCKDOWNS ON GASTROINTESTINAL DISEASE HOSPITALIZATIONS, INPATIENT MORTALITY, AND ENDOSCOPY UTILIZATION IN CALIFORNIA: A STATE-WIDE POPULATION-LEVEL ANALYSIS
por: Adekunle, Ayooluwatomiwa D., et al.
Publicado: (2022)

Trends in gastrointestinal disease hospitalizations and outcomes during the first year of the coronavirus pandemic
por: Adekunle, Ayooluwatomiwa Deborah, et al.
Publicado: (2023)

EP1195: COVID-19 INFECTION AND BREAKTHROUGH INFECTION IN POST LIVER TRANSPLANT PATIENTS
por: Moein, Hamid-Reza, et al.
Publicado: (2022)

Tu1270: SEROLOGICAL RESPONSE TO SARS-COV-2 VACCINES IN LIVER TRANSPLANT PATIENTS
por: Toapanta-Yanchapaxi, Liz, et al.
Publicado: (2022)

Su1373: UTILIZATION OF DRUG OVERDOSE DONORS FOR LIVER TRANSPLANTATION DURING COVID-19 PANDEMIC
por: Lymberopoulos, Peter, et al.
Publicado: (2022)

Su317 CORONAVIRUS DISEASE 2019 AND LIVER INJURY: A RETROSPECTIVE ANALYSIS OF HOSPITALIZED PATIENTS IN NEW YORK CITY
por: Bender, Joshua M., et al.
Publicado: (2021)

435 INCIDENCE AND MORTALITY OF COVID-19 IN POST-LIVER TRANSPLANT PATIENTS IN A LARGE INTEGRATED HEALTHCARE SYSTEM
por: Tien, Andy, et al.
Publicado: (2021)

9 ELEVATED LIVER ENZYMES PORTENDS A HIGHER RATE OF COMPLICATIONS AND DEATH IN ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)
por: Currier, Emily E., et al.
Publicado: (2021)

Tu1268: LONGITUDINAL ASSESSMENT OF SEROLOGICAL RESPONSE AFTER THREE DOSES OF SARS-COV-2 MRNA VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Gandle, Cassandra, et al.
Publicado: (2022)

Su318 PATTERNS OF LIVER TRANSPLANTATION EVALUATIONS FOR HOSPITALIZED ADULTS WITH ACUTE ALCOHOLIC HEPATITIS DURING COVID-19: A SINGLE CENTER STUDY
por: Bangaru, Saroja, et al.
Publicado: (2021)

783: INCIDENCE AND OUTCOMES OF COVID-19 IN POST-LIVER TRANSPLANT RECIPIENTS AFTER COVID-19 VACCINATION IN A LARGE INTEGRATED HEALTHCARE SYSTEM
por: Tien, Andy, et al.
Publicado: (2022)

Tu1267: TELEMEDICINE DURING COVID-19 PANDEMIC IS AN ACCEPTABLE MODALITY FOR LIVER CARE DELIVERY IN VULNERABLE POPULATIONS WITH FATTY LIVER DISEASE
por: Khalili, Mandana, et al.
Publicado: (2022)

Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Tu1260: IMPACT OF COVID-19 ON PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS
por: Moga, Tudor V., et al.
Publicado: (2022)

10 IMPACT OF CHRONIC LIVER DISEASE ON THE COVID-19 HOSPITAL ADMITTED PATIENTS
por: Amjad, Waseem, et al.
Publicado: (2021)

Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
por: Kalligeros, Markos, et al.
Publicado: (2022)

Su324 THE IMPACT OF THE COVID-19 PANDEMIC ON LIVER BIOMARKERS AND QUALITY OF LIFE IN PATIENTS WITH NAFLD
por: Clarke, Lindsay M., et al.
Publicado: (2021)

EP1192: LIVER TEST ABNORMALITIES IN COVID-19 PATIENTS MAY NOT BE RELATED TO CYTOKINE STORM
por: Piskorz, Maria, et al.
Publicado: (2022)

Tu1266: VARIABLE IMPACT OF COVID-19 PANDEMIC ON HOSPITALIZATION FOR ALCOHOL-ASSOCIATED LIVER DISEASE.
por: Lee, Tai-Ping, et al.
Publicado: (2022)

Mo1336: PREVALENCE AND MORTALITY OF ALCOHOL-RELATED LIVER DISEASES DURING COVID-19 PANDEMIC
por: Yeo, Yee Hui, et al.
Publicado: (2022)

8 PREDICTORS OF OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
por: Sandhu, Sunny, et al.
Publicado: (2021)

Su323 THE PATTERNS OF LIVER INJURY IN COVID-19 POSITIVE PREGNANT FEMALES: A CASE SERIES
por: Raju, Sneha, et al.
Publicado: (2021)

Su325 HEPATIC STEATOSIS MAY LEAD TO WORSE OUTCOMES IN PATIENTS WITH LIVER INJURY AND COVID-19
por: Shaikh, Danial H., et al.
Publicado: (2021)

EP1194: THE PROGNOSTIC IMPLICATIONS OF LIVER FUNCTION TEST ABNORMALITIES IN PATIENTS ADMITTED TO HOSPITAL WITH COVID-19
por: Cohen, Jason, et al.
Publicado: (2022)

Mo1330: THE IMPACT OF COVID-19 ON ALCOHOLIC LIVER DISEASES IN A PREDOMINANTLY AFRICAN AMERICAN AND HISPANIC COMMUNITY
por: Sun, Haozhe, et al.
Publicado: (2022)

7 A RETROSPECTIVE ANALYSIS OF COVID-19 INFECTED PATIENTS WITH ACUTE LIVER FAILURE IN A SAFETY NET HOSPITAL
por: Pellegrini, James R., et al.
Publicado: (2021)

Tu1256: METFORMIN USE IS ASSOCIATED WITH LESS FREQUENT SEVERE LIVER INJURY UPON HOSPITAL ADMISSIN WITH COVID-19
por: Kuntzen, Christian, et al.
Publicado: (2022)

A63 TRENDS AND OUTCOMES OF LIVER DISEASE HOSPITALIZATIONS DURING THE CORONAVIRUS PANDEMIC IN THE UNITED STATES: A NATIONWIDE POPULATION-LEVEL ANALYSIS
por: Sedarous, M, et al.
Publicado: (2023)

EP1193: A NOVEL PROGNOSTIC MODEL INCLUDING LIVER FUNCTION PARAMETERS ACCURATELY PREDICTS 30-DAY MORTALITY IN PATIENTS ADMITTED WITH COVID-19
por: Lee, David U., et al.
Publicado: (2022)

11 TRENDS IN ALCOHOL RELATED LIVER DISEASE DURING THE SARS-COV 2 PANDEMIC: REAL-TIME ANALYSIS OF SYSTEMWIDE DATA TRENDS USING EPIC SLICERDICER™.
por: Roark, Travis, et al.
Publicado: (2021)

Tu1263: DOES COVID 19 VACCINATION PREVENT LIVER INJURY? – A LONGITUDINAL COMPARISON BETWEEN COVID 19 VACCINATED PATIENTS AND COVID 19 UNVACCINATED PATIENTS.
por: Rammohan, Rajmohan, et al.
Publicado: (2022)

782: COMPARISON OF INFECTION-INDUCED AND VACCINE-INDUCED IMMUNITY AGAINST CORONAVIRUS 2019 IN PATIENTS WITH CIRRHOSIS
por: John, Binu V., et al.
Publicado: (2022)

Introduction to the Revised American Association for the Study of Liver Diseases Position Paper on Acute Liver Failure 2011
por: Lee, William M, et al.
Publicado: (2012)

Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
por: Bacon, Bruce R, et al.
Publicado: (2011)

An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
por: Ghany, Marc G, et al.
Publicado: (2011)

310 Ribavirin coupled to hemoglobin protects against viral hepatitis induced by the corona virus MHV-3 in mice
por: Levy, Gary A., et al.
Publicado: (2003)

437 A TAILORED PROGRAM FOR SCREENING, IMPROVED ACCESS TO CARE, AND PRIORITIZATION OF TREATMENT FOR PWUD WITH CHRONIC HCV INFECTION.
por: Mangia, Alessandra, et al.
Publicado: (2021)

13 CHEMOPREVENTIVE EFFECT OF STATIN ON HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH CIRRHOSIS
por: Al-Yaman, Wael A., et al.
Publicado: (2021)

12 MULTIFOCAL INTRAHEPATIC CHOLANGIOCARCINOMA: IMMUNOGENOMIC AND EPIGENOMIC HETEROGENEITIES INFLUENCE THE RESPONSES TO TARGETED THERAPY AND IMMUNOTHERAPY
por: Chen, Shu-Ling, et al.
Publicado: (2021)

6 CIRRHOSIS IS ASSOCIATED WITH SIGNIFICANTLY WORSENED CLINICAL OUTCOMES OF COVID-19 INFECTION IN A RETROSPECTIVE ANALYSIS OF 23,474 PATIENTS ACROSS 143 HOSPITALS
por: Hwang, Andrew W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_efvvjcjmsgkv38vdau8mh3ht0h